Nuwellis, Inc. (NUWE) has secured U.S. Patent No. 12,357,734 for its “Extracorporeal Blood Filtering Machine and Methods,” officially granted on July 15, 2025, enhancing the company’s intellectual property portfolio.
The patent held by Baxter International (BAX) addresses improvements in fluid balance calculations by factoring in the density of replacement fluids and effluent, tackling errors in continuous renal replacement therapy (CRRT) systems using weight-based measurements.
This latest patent adds to Nuwellis’ extensive and growing collection of pending U.S. patents related to its proprietary systems and methods.
